Share this article on:

The γδ T-cell receptor repertoire is reconstituted in HIV patients after prolonged antiretroviral therapy

Chaudhry, Suchitaa; Cairo, Cristianaa; Venturi, Vanessab; Pauza, C. Davida

doi: 10.1097/QAD.0b013e3283611888
Basic Science: Concise Communication

Objective: Determine whether reconstitution of Vγ2Vδ2 T cells in patients with HIV is due to new cell synthesis with recovery of the T-cell receptor repertoire or proliferative expansion of residual cells from the time of treatment initiation.

Design: Perform a cross-sectional analysis of the T-cell receptor complexity of Vγ2 chain in patients treated for HIV, natural virus suppressors who control viremia to undetectable levels, patients with chronic low-level viremia in the absence of therapy, and uninfected controls. Apply quantitative methods for repertoire analysis to assess the degree of Vδ2 repertoire loss or reconstitution.

Methods: T-cell receptor Vγ2 chain DNA clones (up to 300 per patient sample) were sequenced and aligned to enumerate the antigen-reactive subset with Vγ2-Jγ1.2 rearrangements. Predominant shared (public) sequences in each patient were compared to a reference library of public sequences from uninfected controls to assess the extent of similarity. Repertoire comparisons were quantified through bioinformatics testing.

Results: Patients with prolonged virus suppression due to antiretroviral therapy reconstituted the Vγ2 T-cell repertoire to near-normal levels. Natural virus suppressors were similar to the treatment group. Severe defects in the Vγ2 T-cell receptor repertoire were observed in patients with chronic viremia despite the absence of overt disease.

Conclusion: Prolonged HIV suppression with antiretroviral therapy leads to reconstitution of the Vγ2Vδ2 T-cell subset deleted in HIV disease. Direct evidence for repair of the T-cell receptor repertoire supports a view that treatment-associated immune reconstitution is due to new cell synthesis and not to expansion of residual cell populations.

Supplemental Digital Content is available in the text

aDivision of Basic Science and Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA

bComputational Biology Group, Centre for Vascular Research, University of New South Wales, Kensington, Australia.

Correspondence to C. David Pauza, University of Maryland School of Medicine, Baltimore, MD 20201, USA. E-mail:

Received 2 November, 2012

Revised 22 February, 2013

Accepted 10 March, 2013

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (

© 2013 Lippincott Williams & Wilkins, Inc.